UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer

Cell reports (Cambridge), 2015-04, Vol.11 (1), p.98-110

2015

Volltextzugriff (PDF)

Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region

Structure (London), 2016-05, Vol.24 (5), p.697-709

2016

Volltextzugriff (PDF)

Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding

Proceedings of the National Academy of Sciences - PNAS, 2013-01, Vol.110 (1), p.E69-E78

2013

Volltextzugriff (PDF)

Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection

Proceedings of the National Academy of Sciences - PNAS, 2015-03, Vol.112 (9), p.E992-E999

2015

Volltextzugriff (PDF)

A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus

npj vaccines, 2021-02, Vol.6 (1), p.23-23, Article 23

2021

Volltextzugriff (PDF)

Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection

Molecular systems biology, 2019-05, Vol.15 (5), p.e8747-n/a

2019

Volltextzugriff (PDF)

Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection

Proceedings of the National Academy of Sciences - PNAS, 2009-03, Vol.106 (10), p.3952-3957

2009

Volltextzugriff (PDF)

Identification and Characterization of an Immunogenic Hybrid Epitope Formed by both HIV gp120 and Human CD4 Proteins

Journal of Virology, 2011-12, Vol.85 (24), p.13097-13104

2011

Volltextzugriff (PDF)

Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and Treatment

Current HIV research, 2016-01, Vol.14 (1), p.24-36

2016

Volltextzugriff (PDF)

Adjuvant Activity of the Catalytic A1 Domain of Cholera Toxin for Retroviral Antigens Delivered by GeneGun

Clinical and Vaccine Immunology, 2011-06, Vol.18 (6), p.922-930

2011

Volltextzugriff (PDF)

Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach

Journal of controlled release, 2016-12, Vol.244 (Pt A), p.98-107

2016

Volltextzugriff (PDF)

Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway

Journal of leukocyte biology, 2002-11, Vol.72 (5), p.962-969

2002

Volltextzugriff (PDF)

Expression of Human Immunodeficiency Virus Type 1 Neutralizing Antibody Fragments Using Human Vaginal Lactobacillus

AIDS research and human retroviruses, 2016-11, Vol.32 (10-11), p.964-971

2016

Volltextzugriff (PDF)

Cholera Toxin and Heat-Labile Enterotoxin Activate Human Monocyte-Derived Dendritic Cells and Dominantly Inhibit Cytokine Production through a Cyclic AMP-Dependent Pathway

Infection and Immunity, 2002-10, Vol.70 (10), p.5533-5539

2002

Volltextzugriff (PDF)

An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model

Viral immunology, 2017-04, Vol.30 (3), p.178-195

2017

Volltextzugriff (PDF)

An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques

Clinical and vaccine immunology, 2016-07, Vol.23 (7), p.618-627

2016

Volltextzugriff (PDF)

Expression and Characterization of a Single-Chain Polypeptide Analogue of the Human Immunodeficiency Virus Type 1 gp120-CD4 Receptor Complex

Journal of Virology, 2000-12, Vol.74 (24), p.11427-11436

2000

Volltextzugriff (PDF)

Neutralization of HIV by antibodies

Methods in molecular biology (Clifton, N.J.), 2009, Vol.525, p.517

2009

Volltextzugriff (PDF)

Correlation between Humoral Responses to Human Immunodeficiency Virus Type 1 Envelope and Disease Progression in Early-Stage Infection

The Journal of infectious diseases, 1998-11, Vol.178 (5), p.1306-1316

1998

Volltextzugriff (PDF)

Development of an oral prime–boost strategy to elicit broadly neutralizing antibodies against HIV-1

Vaccine, 2002-05, Vol.20 (15), p.1968-1974

2002

Volltextzugriff (PDF)

Structure and Function of the HIV Envelope Glycoprotein as Entry Mediator, Vaccine Immunogen, and Target for Inhibitors

Advances in Pharmacology, 2007, Vol.55, p.33-97

2007

Volltextzugriff (PDF)

Antibody-based inhibitors of HIV infection

Expert opinion on biological therapy, 2006-05, Vol.6 (5), p.523-531

2006

Volltextzugriff (PDF)

Evidence that Antibody-Mediated Neutralization of Human Immunodeficiency Virus Type 1 by Sera from Infected Individuals Is Independent of Coreceptor Usage

Journal of Virology, 1998-03, Vol.72 (3), p.1886-1893

1998

Volltextzugriff (PDF)

Conserved Structures Exposed in HIV-1 Envelope Glycoproteins Stabilized by Flexible Linkers as Potent Entry Inhibitors and Potential Immunogens

Biochemistry (Easton), 2002-06, Vol.41 (22), p.7176-7182

2002

Volltextzugriff (PDF)

Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses

Journal of biotechnology, 1996-01, Vol.44 (1-3), p.203-207

1996

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(37)
Buchkapitel
(1)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Science & Technology
(32)
Life Sciences & Biomedicine
(29)
Humans
(26)
Immunology
(17)
Hiv Envelope Protein Gp120 - Immunology
(15)
Virology
(15)
Hiv-1 - Immunology
(14)
Animals
(13)
Microbiology
(12)
Biological And Medical Sciences
(11)
Hiv Antibodies - Immunology
(11)
Infectious Diseases
(11)
Aids Vaccines - Immunology
(9)
Human Immunodeficiency Virus 1
(9)
Mice
(9)
Cd4 Antigens - Immunology
(8)
Fundamental And Applied Biological Sciences. Psychology
(8)
Hiv
(8)
Aids/hiv
(7)
Hiv Envelope Protein Gp120 - Genetics
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer

Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region

Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding

Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection

A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus

Antibody Fab‐Fc properties outperform titer in predictive models of SIV vaccine‐induced protection

Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection

Identification and Characterization of an Immunogenic Hybrid Epitope Formed by both HIV gp120 and Human CD4 Proteins

Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and Treatment

Adjuvant Activity of the Catalytic A1 Domain of Cholera Toxin for Retroviral Antigens Delivered by GeneGun

Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach

Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway

Expression of Human Immunodeficiency Virus Type 1 Neutralizing Antibody Fragments Using Human Vaginal Lactobacillus

Cholera Toxin and Heat-Labile Enterotoxin Activate Human Monocyte-Derived Dendritic Cells and Dominantly Inhibit Cytokine Production through a Cyclic AMP-Dependent Pathway

An Interleukin 12 Adjuvanted Herpes Simplex Virus 2 DNA Vaccine Is More Protective Than a Glycoprotein D Subunit Vaccine in a High-Dose Murine Challenge Model

An HIV gp120-CD4 Immunogen Does Not Elicit Autoimmune Antibody Responses in Cynomolgus Macaques

Expression and Characterization of a Single-Chain Polypeptide Analogue of the Human Immunodeficiency Virus Type 1 gp120-CD4 Receptor Complex

Neutralization of HIV by antibodies

Correlation between Humoral Responses to Human Immunodeficiency Virus Type 1 Envelope and Disease Progression in Early-Stage Infection

Development of an oral prime–boost strategy to elicit broadly neutralizing antibodies against HIV-1

Structure and Function of the HIV Envelope Glycoprotein as Entry Mediator, Vaccine Immunogen, and Target for Inhibitors

Antibody-based inhibitors of HIV infection

Evidence that Antibody-Mediated Neutralization of Human Immunodeficiency Virus Type 1 by Sera from Infected Individuals Is Independent of Coreceptor Usage

Conserved Structures Exposed in HIV-1 Envelope Glycoproteins Stabilized by Flexible Linkers as Potent Entry Inhibitors and Potential Immunogens

Optimization of live oral Salmonella-HIV-1 vaccine vectors for the induction of HIV-specific mucosal and systemic immune responses

Suchergebnisse filtern